Annual EBIT
-$158.23 M
-$55.45 M-53.96%
December 31, 2024
Summary
- As of March 3, 2025, GPCR annual earnings before interest & taxes is -$158.23 million, with the most recent change of -$55.45 million (-53.96%) on December 31, 2024.
- During the last 3 years, GPCR annual EBIT has fallen by -$120.53 million (-319.75%).
- GPCR annual EBIT is now -894.77% below its all-time high of -$15.91 million, reached on December 1, 2020.
Performance
GPCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$47.06 M
-$1.23 M-2.67%
December 31, 2024
Summary
- As of March 3, 2025, GPCR quarterly earnings before interest & taxes is -$47.06 million, with the most recent change of -$1.23 million (-2.67%) on December 31, 2024.
- Over the past year, GPCR quarterly EBIT has dropped by -$1.23 million (-2.67%).
- GPCR quarterly EBIT is now -270.76% below its all-time high of -$12.69 million, reached on September 30, 2022.
Performance
GPCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$158.23 M
-$16.07 M-11.30%
December 31, 2024
Summary
- As of March 3, 2025, GPCR TTM earnings before interest & taxes is -$158.23 million, with the most recent change of -$16.07 million (-11.30%) on December 31, 2024.
- Over the past year, GPCR TTM EBIT has dropped by -$16.07 million (-11.30%).
- GPCR TTM EBIT is now -1092.01% below its all-time high of -$13.27 million, reached on December 1, 2021.
Performance
GPCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
GPCR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.0% | -2.7% | -11.3% |
| 3 y3 years | -319.8% | -2.7% | -11.3% |
| 5 y5 years | -894.8% | -2.7% | -11.3% |
GPCR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -319.8% | at low | -270.8% | at low | -1092.0% | at low |
| 5 y | 5-year | -894.8% | at low | -270.8% | at low | -1092.0% | at low |
| alltime | all time | -894.8% | at low | -270.8% | at low | -1092.0% | at low |
Structure Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$158.23 M(+54.0%) | -$47.06 M(+2.7%) | -$158.23 M(+11.3%) |
| Sep 2024 | - | -$45.84 M(+37.6%) | -$142.16 M(+16.1%) |
| Jun 2024 | - | -$33.32 M(+4.1%) | -$122.47 M(+6.4%) |
| Mar 2024 | - | -$32.02 M(+3.3%) | -$115.14 M(+12.0%) |
| Dec 2023 | -$102.78 M | -$30.99 M(+18.5%) | -$102.78 M(+21.3%) |
| Sep 2023 | - | -$26.14 M(+0.6%) | -$84.74 M(+18.9%) |
| Jun 2023 | - | -$25.99 M(+32.3%) | -$71.28 M(+20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$19.65 M(+51.7%) | -$59.26 M(+12.7%) |
| Dec 2022 | -$52.56 M(+39.4%) | -$12.96 M(+2.1%) | -$52.56 M(-0.6%) |
| Sep 2022 | - | -$12.69 M(-9.1%) | -$52.88 M(+31.6%) |
| Jun 2022 | - | -$13.96 M(+7.8%) | -$40.19 M(+53.2%) |
| Mar 2022 | - | -$12.95 M(-2.4%) | -$26.23 M(+97.6%) |
| Dec 2021 | -$37.70 M(+137.0%) | - | - |
| Dec 2021 | - | -$13.27 M | -$13.27 M |
| Dec 2020 | -$15.91 M | - | - |
FAQ
- What is Structure Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Structure Therapeutics?
- What is Structure Therapeutics annual EBIT year-on-year change?
- What is Structure Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Structure Therapeutics?
- What is Structure Therapeutics quarterly EBIT year-on-year change?
- What is Structure Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Structure Therapeutics?
- What is Structure Therapeutics TTM EBIT year-on-year change?
What is Structure Therapeutics annual earnings before interest & taxes?
The current annual EBIT of GPCR is -$158.23 M
What is the all time high annual EBIT for Structure Therapeutics?
Structure Therapeutics all-time high annual earnings before interest & taxes is -$15.91 M
What is Structure Therapeutics annual EBIT year-on-year change?
Over the past year, GPCR annual earnings before interest & taxes has changed by -$55.45 M (-53.96%)
What is Structure Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of GPCR is -$47.06 M
What is the all time high quarterly EBIT for Structure Therapeutics?
Structure Therapeutics all-time high quarterly earnings before interest & taxes is -$12.69 M
What is Structure Therapeutics quarterly EBIT year-on-year change?
Over the past year, GPCR quarterly earnings before interest & taxes has changed by -$1.23 M (-2.67%)
What is Structure Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of GPCR is -$158.23 M
What is the all time high TTM EBIT for Structure Therapeutics?
Structure Therapeutics all-time high TTM earnings before interest & taxes is -$13.27 M
What is Structure Therapeutics TTM EBIT year-on-year change?
Over the past year, GPCR TTM earnings before interest & taxes has changed by -$16.07 M (-11.30%)